About Agios (AGIO)
Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more
- USD40.68
- USD41.67
- USD40.18
- USD53.29
- -6.40%
- 31M
- 113.63k
- 628.70k
- 2.4B
- 19.80
- 68.80%
Stock News
3 hours ago
Prediction: This Artificial Intelligence (AI) Software Company Could Be the Next Palantir
Yahoo
3 hours ago
Biogen’s stock bounces after FDA boost on kidney-transplant rejection treatment
MarketWatch
4 hours ago
Citi turns more bullish on cruise stocks
Yahoo
4 hours ago
Kenvue Inc.'s (NYSE:KVUE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
